To evaluate the results of treatment of prostate cancer by endocrine therapy. Subjects and methods: All cases with prostate cancer were diagnosed by histopathology, treated by endocrine. Evaluating the results after 3 months, 6 months, and over 1 year. | Journal of military pharmaco-medicine no1-2019 ASSESMENT OF TREATMENT OF PROSTATE CANCER BY ENDOCRINE THERAPY AT 103 MILITARY HOSPITAL Nguyen Anh Tuan1; Tran Van Hinh1; Pham Quang Vinh1; Nguyen Phu Viet1 Dao Van Nhat1; Nguyen Dinh Duong1; Cao Quyet Thang1; Le Anh Tuan1 SUMMARY Objectives: To evaluate the results of treatment of prostate cancer by endocrine therapy. Subjects and methods: All cases with prostate cancer were diagnosed by histopathology, treated by endocrine. Evaluating the results after 3 months, 6 months, and over 1 year. Results: After endocrine therapy over 12 months, PSA total level 10 ng/mL: . PSA total level decreased from ± ng/mL to ± ng/mL (p 10 ng/mL (). The total PSA level decreased from ± ng/mL to ± ng/mL, significantly different with p 10 ng/mL; there are distant metastases. * Data processing: + Diagnosed finally prostate cancer by histopathology. Data were entered and processed by statistical software in SPSS and Excel 2010. + Used endocrine agents with enough dose and times at 103 Military Hospital. RESULTS AND DISCUSSION + Full documentation of clinical, treatment and development during hospitalization. - Exclusion criteria: + Patients do not agree to enroll in the study. + Patients who are diagnosed with histopathology and treatment by other medical centers. Patients diagnosed with prostate cancer without histologic results, incomplete records of treatment and follow-up. 2. Methods. - Case, description study. - Process: Patients were diagnosed with prostate biopsy on histopathology, histopathological classification, Gleason score, blood PSA level before and after endocrine treatment 3 months, 6 months and over 1 year. - Endocrine agents: Diphereline mg every 3 months. 146 1. Characteristics of patients. * Age of patients (n = 48): 80 years old: 17 patients (). The mean age of patients with prostate cancer in this study was ± . The youngest was 48, the .
